-
Modi et al. and colleagues from the Centers for Disease Control and Prevention examined reports of tuberculosis in the Quarantine Activity Reporting System (QARS) from June 1, 2007, through May 31, 2008 (year 2) and compared the data to those of the previous year, June 1, 2006, through May 31, 2007 (year 1).
-
A complaint to Idaho's Central District Health Department of several ill persons with watery diarrhea consistent with cryptosporidiosis triggered an investigation of splash park visitors who attended reservation-only gatherings.
-
In this issue: Efficacy of once-daily insulin, aldo-sterone use in heart failure, erectile dysfunction Clinical Practice Guidelines, and FDA Actions.
-
-
More than 75% of parents surveyed in a nationwide study would be willing to allow their children's newborn screening samples to be used for future research if researchers first asked their permission.
-
In an effort to address the wide variance in state laws and policies regarding the research use of newborn screening blood spots, a federal advisory committee is considering a proposal for a national policy.
-
As bioethicists and other experts in human subjects research protection take a closer look at the IRB's role, two interesting questions emerge: First, how can IRBs improve their risk-benefit analyses of trials, and, secondly, should IRBs even be in the business of making risk-benefit determinations?
-
The use of deep brain stimulation (DBS) in the treatment of Parkinson's disease and other neurological disorders has been the subject of many research studies and has been approved by the Food and Drug Administration since 1997.
-
Written informed consent will exist in human subjects research for as long as regulations require it, but this doesn't mean IRBs and investigators are stuck within its limitations.
-
It's likely one of the first medical procedures most newborn babies undergo a simple heel stick, as blood samples are taken to screen for a variety of disorders that might not otherwise be apparent at birth.
